1. 464OInduction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study. (24th November 2019) Authors: Saeki, S; Hotta, K; Yamaguchi, M; Harada, D; Bessho, A; Tanaka, K; Inoue, K; Gemba, K; Inoue, K; Ichihara, E; Kishimoto, J; Sasaki, T; Shioyama, Y; Katsui, K; Sasaki, J; Kiura, K; Sugio, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 528PThe impact of continuing ALK inhibitors beyond initial disease progression on clinical outcome in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter retrospective analysis. (25th November 2018) Authors: Sakata, S; Saeki, S; Sakata, Y; Kawamura, K; Ichikado, K; Inaba, M; Ushijima, S; Imamura, K; Iyonaga, K; Kumabe, T; Fujita, R; Kashiwabara, K; Fujii, S; Komatsu, T; Sakamoto, O; Okabayashi, H; Saruwatari, K; Tomita, Y; Sakagami, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Issue 4 (1st October 1998) Authors: Ohba, K; Omagari, K; Nakamura, T; Ikuno, N; Saeki, S; Matsuo, I; Kinoshita, H; Masuda, J; Hazama, H; Sakamoto, I; Kohno, S Journal: Gut Issue: Volume 43:Issue 4(1998) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗